Galway, Ireland and Oceanside, CA, USA.  28 July, 2023.  Seroba’s portfolio company, Palliare, a leading developer of advanced insufflation technologies, has received EU CE Mark certification under the new EU Medical Devices Regulation (MDR) for its […]

31 January 2023.  Galway, Ireland and Oceanside, California, USA.  Palliare, a leading developer of advanced insufflation technologies, has received an expanded 510(k) indication from the U.S. Food and Drug Administration for its EVA15 Insufflator to provide […]

Galway, Ireland.  15 July 2021.  Seroba portfolio company, Palliare, an emerging company with the vision to create a safer operating room, has announced that it has received FDA 510(k) clearance for its END-200 tubeset, which extends […]

Galway, Ireland.  28 June 2021.  Palliare, an emerging company with the vision to create a safer operating room, has announced the closing of an oversubscribed $8 million Series A funding round. The round was led by […]